High-Dose Recombinant Interleukin 2 Therapy for Patients With Metastatic Melanoma: Analysis of 270 Patients Treated Between 1985 and 1993 PURPOSE: To report the results of a conservative multimodal ...
The FDA approved oral gepotidacin (Blujepa) for uncomplicated urinary tract infections (UTIs) in women and girls ages 12 years and up, GSK announced on Tuesday. Results of two phase III trials -- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results